LifeStance Health Group, Inc. Common Stock(LFST)
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
- 52-Week Range
- $3.74 – $8.89
- YTD
- +23.42%
- IV Rank (30D)
- 22.39
- Straddle Price
- $1.05
- P/C Vol Ratio
- 0.91
- Market Cap
- $3.3B
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 0.5% and dividend payments are stable.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.53% |
| Beta vs SPY | 1.00 |
| Cost of Equity (CAPM) | 10.03% (VRP-adj) |
| WACC | 9.54% |
| Volatility Risk Premium | +40.2pp (IV − HV30), ERP adj +50bps |
| Effective Tax Rate | 30.9% |
| Rev. Growth (YoY, DCF input) | +16.8% |
| DCF Horizon | 10 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.10 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $0.1B |
| Return on Equity (TTM) | 1.6% |
| Book / Price | 43.9% — banking bias active (P/B is primary) |
| Gross Margin (TTM) | 32.6% |
| FCF Margin (TTM) | 9.5% |
| Debt / Equity | 0.18 |
| Quality Score | 3/6 — normal (10y DCF) |
| Market-Implied Growth | +11.2% (reverse-DCF on current price) |
| SMA 50 | $7.33 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $7.70 |
| Bollinger Width / SMA20 | 179.4% (drives anchor stability) |
| Net Debt | $0.1B |
| Market Cap | $3B |
| Horizon | Expected α | z Pred | Blended z | Rank % | Active? |
|---|---|---|---|---|---|
| 21d | -2.5% | +0.14 | -0.43 | 90.3% | — |
| 42d | -5.0% | -0.13 | -0.43 | 90.3% | — |
| 63d | -5.5% | -0.15 | -0.43 | 90.3% | — |
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $11.97 | 27% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | $3.62 | 7% | median 54.8× · 3 peers |
| Peer EV/EBITDA | $2.66 | 8% | median 10.2× · 3 peers |
| Peer P/B | $10.29 | 11% | median 2.7× · 3 peers |
| Peer P/S | $5.39 | 11% | median 1.3× · 3 peers |
| Market Anchor (SMA50) | $7.33 | 37% | stability 68% (BB-width) |
| Options Expected (B-L 30d) | n/a | 0% |
- Industry (SIC)
- SERVICES-HEALTH SERVICES (8000)
- Exchange
- XNAS
- Market Cap
- $3.3B
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
| Month | Avg Return | Years of Data |
|---|---|---|
| Jan | -5.11% | 5 |
| Feb | +17.83% | 5 |
| Mar | +5.40% | 5 |
| Apr | -1.35% | 5 |
| May | -2.44% | 5 |
| Jun | +1.23% | 6 |
| Jul | -1.32% | 5 |
| Aug | -6.66% | 5 |
| Sep | +2.75% | 5 |
| Oct | -7.42% | 5 |
| Nov | -1.74% | 5 |
| Dec | +4.92% | 5 |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.
Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2024-08-08 | After-Close | 13.58% | 4.92% | 0.36x | Within |
| 2024-11-07 | Pre-Market | 9.12% | 7.71% | 0.85x | Within |
| 2025-02-27 | Pre-Market | 11.68% | 3.29% | 0.28x | Within |
| 2025-05-07 | After-Close | 16.74% | 5.61% | 0.34x | Within |
| 2025-08-07 | Pre-Market | 15.38% | 1.03% | 0.07x | Within |
| 2025-11-06 | Pre-Market | 17.15% | 26.41% | 1.54x | Exceeded |
| 2026-02-25 | After-Close | 15.48% | 5.93% | 0.38x | Within |
| 2026-05-07 | After-Close | 8.76% | 12.99% | 1.48x | Exceeded |
- IV Rank (30D)
- 22.39
- IV Rank (7D)
- 100
- Avg IV
- 102.5%
- Straddle (30D)
- $1.05
- Straddle (7D)
- $0.62
- P/C Volume
- 0.91
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR25 and BF25 from the live options chain. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Enter a ticker to render the implied volatility surface.
- Beta (1Y vs SPY)
- 1.03
- Correlation (SPY)
- 22.7%
- R²
- 0.05
- Ann. Volatility
- 56.0%
- SPY Volatility
- 12.3%
Above average volatility - stock moves with market amplification
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | WOLVERINE TRADING, LLC Custodian | $2.07M | 70.98% | 2025-09-30 |
| 2 | MILLENNIUM MANAGEMENT LLC Custodian | $477.75K | 16.41% | 2026-03-31 |
| 3 | SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian | $198.74K | 6.83% | 2026-03-31 |
| 4 | CITADEL ADVISORS LLC Custodian | $82.17K | 2.82% | 2026-03-31 |
| 5 | Parcion Private Wealth LLC | $63.70K | 2.19% | 2026-03-31 |
| 6 | HAP TRADING, LLC | $22.54K | 0.77% | 2025-09-30 |
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | SIMPLEX TRADING, LLC Custodian | $31.85K | 100.00% | 2026-03-31 |
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-05-14 | DARREN M. BLACK | Director | Sell (S) | −5,899,661 | $8.02 | -$47.32M | EDGAR |
| 2026-05-14 | Eric Shuey | Director | Sell (S) | −243,362 | $8.02 | -$1.95M | EDGAR |
| 2026-05-14 | Robert Bessler | Director | Sell (S) | −575,034 | $8.02 | -$4.61M | EDGAR |
| 2026-05-14 | JAMES G COULTER | 10%+ Owner | Sell (S) | −84,845,829 | $8.02 | -$680.46M | EDGAR |
| 2026-05-11 | Robert Bessler | Director | Sell (S) | −75,000 | $8.55 | -$641.2K | EDGAR |
| 2026-04-27 | Robert Bessler | Director | Sell (S) | −69,899 | $7.04 | -$492.4K | EDGAR |
| 2026-04-23 | Robert Bessler | Director | Sell (S) | −5,101 | $7.01 | -$35.8K | EDGAR |
| 2026-04-03 | Ryan Pardo | See Remarks | Tax (F) | −9,376 | $6.37 | -$59.7K | EDGAR |
| 2026-03-26 | Ryan McGroarty | See Remarks | Tax (F) | −24,255 | $6.45 | -$156.4K | EDGAR |
| 2026-03-19 | Ryan McGroarty | See Remarks | Tax (F) | −47,594 | $6.89 | -$327.9K | EDGAR |
| 2026-03-11 | Lisa K Miller | Chief Operating Officer | Mixed | −1,376 | $6.91 | -$194.9K | EDGAR |
| 2026-03-11 | Kenneth A Burdick | Director | Mixed | +413,295 | $6.91 | -$2.26M | EDGAR |
| 2026-03-11 | David Bourdon | Chief Executive Officer | Mixed | +180,162 | $6.91 | -$1.03M | EDGAR |
| 2026-03-11 | Vukasin Paunovich | Chief Technology Officer | Mixed | +44,394 | $6.91 | -$128.1K | EDGAR |
| 2026-03-11 | Ryan McGroarty | See Remarks | Mixed | +116,473 | $6.91 | -$529.1K | EDGAR |
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | JAMES G COULTER | 10%+ Owner | 111,744,614 | $949.83M | -$903.56M | 2 | 2026-05-14 |
| 2 | SUMMIT MASTER COMPANY, LLC | 46,875,407 | $398.44M | -$139.70M | 1 | 2021-06-16 | |
| 3 | Summit Partners Growth Equity Fund IX-B, L.P. | 10%+ Owner | 46,875,407 | $398.44M | -$116.42M | 1 | 2021-06-16 |
| 4 | SUMMIT PARTNERS ENTREPRENEUR ADVISORS GP II, LLC | 45,734,703 | $388.74M | -$116.42M | 1 | 2021-06-29 | |
| 5 | Summit Partners Growth Equity Fund IX-A, L.P. | 10%+ Owner | 41,932,358 | $356.43M | -$209.00M | 2 | 2024-05-29 |
| 6 | SUMMIT PARTNERS GE IX, L.P. | 41,932,358 | $356.43M | -$134.37M | 1 | 2024-05-29 | |
| 7 | SUMMIT INVESTORS GE IX/VC IV, LLC | 33,524,715 | $284.96M | -$255.76M | 1 | 2025-08-20 | |
| 8 | DARREN M. BLACK | Director | 23,310,115 | $198.14M | -$185.27M | 6 | 2026-05-14 |
| 9 | Michael K. Lester | President and CEO | 23,148,931 | $196.77M | -$1.75M | 2 | 2022-06-14 |
| 10 | JEFFREY CRISAN | Director | 17,916,554 | $152.29M | -$27.81M | 3 | 2024-05-29 |
| 11 | Silversmith Capital Partners I-C, L.P. | 17,916,554 | $152.29M | -$47.85M | 1 | 2024-05-29 | |
| 12 | Silversmith Partners I GP, LLC | 10%+ Owner | 14,324,197 | $121.76M | -$182.26M | 3 | 2025-08-20 |
| 13 | Gwen H. Booth | Chief Operating Officer | 7,083,637 | $60.21M | -$468.0K | 2 | 2022-06-14 |
| 14 | Warren Gouk | Chief Administrative Officer | 5,996,104 | $50.97M | -$4.60M | 23 | 2023-09-05 |
| 15 | Danish J. Qureshi | See Remarks | 5,416,943 | $46.04M | -$3.45M | 11 | 2024-06-18 |
| 16 | Kevin Michael Mullins | Chief Development Officer | 4,650,571 | $39.53M | -$11.30M | 23 | 2024-06-13 |
| 17 | Ryan Pardo | See Remarks | 3,644,886 | $30.98M | -$1.44M | 15 | 2026-04-03 |
| 18 | Kenneth A Burdick | Director | 3,056,259 | $25.98M | -$849.4K | 9 | 2026-03-11 |
| 19 | Anisha Patel-Dunn | Chief Medical Officer | 2,371,505 | $20.16M | -$98.3K | 5 | 2023-06-29 |
| 20 | Jesse Michael Bruff | Chief Financial Officer | 1,928,369 | $16.39M | -$146.5K | 3 | 2022-04-26 |
| 21 | David Bourdon | Chief Executive Officer | 1,484,271 | $12.62M | -$407.7K | 7 | 2026-03-11 |
| 22 | Pablo Pantaleoni | Chief Digital Officer | 1,437,881 | $12.22M | -$666.1K | 11 | 2025-05-19 |
| 23 | Eric Shuey | Director | 961,544 | $8.17M | -$1.95M | 4 | 2026-05-14 |
| 24 | Felicia Gorcyca | Chief People Officer | 909,582 | $7.73M | -$14.1K | 2 | 2022-06-14 |
| 25 | Ryan McGroarty | See Remarks | 772,235 | $6.56M | $0 | 7 | 2026-03-26 |
| 26 | William Joseph Miller | Director | 459,880 | $3.91M | $0 | 2 | 2024-08-27 |
| 27 | Ann Varanakis | Chief People Officer | 447,061 | $3.80M | -$528.1K | 11 | 2026-03-11 |
| 28 | Lisa K Miller | Chief Operating Officer | 342,647 | $2.91M | -$576.6K | 8 | 2026-03-11 |
| 29 | Vukasin Paunovich | Chief Technology Officer | 309,296 | $2.63M | $0 | 3 | 2026-03-11 |
| 30 | Paula Cipollone | See Remarks | 239,915 | $2.04M | -$484.7K | 3 | 2024-05-14 |
| 31 | Teresa DeLuca | Director | 143,651 | $1.22M | $0 | 3 | 2025-06-13 |
| 32 | Seema Verma | Director | 137,811 | $1.17M | $0 | 3 | 2024-08-27 |
| 33 | Stephanie Carin Eken | Chief Medical Officer | 115,107 | $978.4K | $0 | 1 | 2026-03-09 |
| 34 | Ujjwal Ramtekkar | Chief Medical Officer | 103,916 | $883.3K | -$144.3K | 5 | 2025-06-18 |
| 35 | Robert Bessler | Director | 93,982 | $798.8K | -$7.93M | 12 | 2026-05-14 |
| 36 | Sarah Personette | Director | 74,766 | $635.5K | $0 | 1 | 2025-10-28 |
| 37 | Eric P Palmer | Director | 71,428 | $607.1K | $0 | 1 | 2025-06-13 |
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
| P/E Ratio | 143.2 |
| P/B Ratio | 2.2 |
| P/S Ratio | 2.2 |
| EV/EBITDA | 34.1 |
| TTM Revenue | $1.5B |
| TTM Net Income | $0.0B |
| TTM EPS | $0.06 |
| ROE | 1.6% |
| Debt/Equity | 0.18 |